Merck KGaA is shaping up to take on Daiichi Sankyo and Ono Pharma in the market for tenosynovial giant cell tumour (TGCT) ...

Target patient enrollment of 92 evaluable patients achieved in the VIRAGE Phase 2b clinical trial of VCN-01 in patients with metastatic ...

Abbisko announces positive results from phase 3 MANEUVER study of pimicotinib to treat tenosynovial giant cell tumour: Shanghai Wednesday, November 13, 2024, 18:00 Hrs [IST] Abbis ...

During his preceding 12-year tenure at Morphosys, most recently leading clinical biomarkers and companion diagnostics, he supported the company’s transition into a commercial stage ... with MSD ...

This eases the user's understanding of the market thoroughly, while also gaining knowledge about Anxiety Disorder Treatment market opportunities and the dominant players Pfizer Inc, Merck KGaA ...

The long, strange trip to turn psychedelic drugs into approved medicines has hit a bad batch of developments in recent months ...

Inaugural Process Innovation Asia Pacific builds on global process industry's premier showcase ACHEMA's legacy and expertise, convening global industry leaders to drive sustainable growth for Asia's ...

Chronic Lower Back Pain (CLBP) market Research Report Covers, Future Trends, Past, Present Data and Deep Analysis ...

During his preceding 12-year tenure at Morphosys, most recently leading clinical biomarkers and companion diagnostics, he supported the company's transition into a commercial stage ... with MSD ...

Ginkgo provides update on its restructuring process including an acceleration of site consolidation initiatives and continued progress on cost reductions Ginkgo signs ...